- Home
- IMRX vs RLTY Comparison
IMRX vs RLTY Comparison
Compare IMRX & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMRX | RLTY |
|---|---|---|
| Founded | 2008 | 2022 |
| Country | United States | United States |
| Employees | 57 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.3M | 262.5M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | IMRX | RLTY |
|---|---|---|
| Price | $3.62 | $13.89 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $17.17 | N/A |
| AVG Volume (30 Days) | ★ 663.1K | 72.7K |
| Earning Date | 11-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.35% |
| EPS Growth | ★ 37.75 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.38 | $13.34 |
| 52 Week High | $8.48 | $16.41 |
Technical Indicators
Market Signals| Indicator | IMRX | RLTY |
|---|---|---|
| Relative Strength Index (RSI) | 35.41 | 41.77 |
| Support Level | N/A | $13.34 |
| Resistance Level | $5.32 | $15.92 |
| Average True Range (ATR) | 0.18 | 0.24 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 31.18 | 60.79 |
Price Performance
Historical ComparisonAbout IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income. Its secondary investment objective is capital appreciation. The fund invests the majority of its managed assets in real estate-related investments and preferred and other income securities.